학술논문

PGL-III, a Rare Intermediate of Mycobacterium lepraePhenolic Glycolipid Biosynthesis, Is a Potent Mincle Ligand
Document Type
Article
Source
ACS Central Science; July 2023, Vol. 9 Issue: 7 p1388-1399, 12p
Subject
Language
ISSN
23747943; 23747951
Abstract
Although leprosy (Hansen’s disease) is one of the oldest known diseases, the pathogenicity of Mycobacterium leprae(M. leprae) remains enigmatic. Indeed, the cell wall components responsible for the immune response against M. lepraeare as yet largely unidentified. We reveal here phenolic glycolipid-III (PGL-III) as an M. leprae-specific ligand for the immune receptor Mincle. PGL-III is a scarcely present trisaccharide intermediate in the biosynthetic pathway to PGL-I, an abundant and characteristic M. lepraeglycolipid. Using activity-based purification, we identified PGL-III as a Mincle ligand that is more potent than the well-known M. tuberculosistrehalose dimycolate. The cocrystal structure of Mincle and a synthetic PGL-III analogue revealed a unique recognition mode, implying that it can engage multiple Mincle molecules. In Mincle-deficient mice infected with M. leprae, increased bacterial burden with gross pathologies were observed. These results show that PGL-III is a noncanonical ligand recognized by Mincle, triggering protective immunity.